The Supply of the Drug "Rusolitinib" as Part of the Preferential Drug Support for 2025. (P25-02-2668)

RussiaTenders notice for The Supply of the Drug "Rusolitinib" as Part of the Preferential Drug Support for 2025. (P25-02-2668). The reference ID of the tender is 118477103 and it is closing on 13 May 2025.

100% Secure Payments

Tender Details

  • Country: Russia
  • Summary: The Supply of the Drug "Rusolitinib" as Part of the Preferential Drug Support for 2025. (P25-02-2668)
  • RUT Ref No: 118477103
  • Deadline: 13 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 2193676.80
  • Notice Type: Tender
  • Document Ref. No.: 0142200001325011303
  • Purchaser's Detail :
  • Purchaser : COMMITTEE FOR THE ORGANIZATION OF TRADING OF THE SAMARA REGION
    Russian Federation, 443068, Samara region, Samara G, Sklyarenko, Sklyarenko Ul, D.20
    F.I.o:-Katina E.V.
    Number of contact phone:-8-846-214322
    fax:-7-846-3351228
    Email :torgi@samregion.ru

  • Description :
  • The supply of the drug "Rusolitinib" as part of the preferential drug support for 2025. (P25-02-2668)
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us